2-Amino-6-chlorobenzoxazole

Catalog No. :
ACZAEQ854
CAS No. :
52112-68-2
Molecular Formula :
C7H5ClN2O
Molecular Weight :
168.58

IUPAC Name:6-chlorobenzo[d]oxazol-2(3H)-imine

2-Amino-6-chlorobenzoxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$51.00Login to see priceIn stockIn stock
25g97%$193.00Login to see priceIn stockIn stock
100g97%$748.00Login to see priceInquiryInquiry
500g97%$2693.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Amino-6-chlorobenzoxazole
IUPAC Name6-chlorobenzo[d]oxazol-2(3H)-imine
MDL No.MFCD01664218
Molecular FormulaC7H5ClN2O
Molecular Weight168.58
SMILESClC1=CC2=C(NC(=N)O2)C=C1
InChI KeyQDMXVLGVKMTTIT-UHFFFAOYSA-N
Synonym2-Amino-6-chlorobenzoxazole | 52112-68-2 | 6-Chlorobenzo[d]oxazol-2-amine | 6-chloro-1,3-benzoxazol-2-amine | 2-Benzoxazolamine, 6-chloro- | 6-Chloro-2-benzoxazolamine | BENZOXAZOLE, 2-AMINO-6-CHLORO- | MLS002639031 | CHEMBL1889525 | MFCD01664218 | NSC 24991 | NSC24991 | cid_402
CAS No.52112-68-2
PubChem CID40237

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACZAEQ854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACZAEQ854 route product structure diagram
    ACZAEQ85452112-68-2 In Stock
Inquiry

2. ACZAEQ854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACZAEQ854 route product structure diagram
    ACZAEQ85452112-68-2 In Stock
Inquiry

Comments (0)